Full text
PDFPage 440
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergqvist D., Mätzsch T. Cost/benefit aspects on thromboprophylaxis. Haemostasis. 1993 Mar;23 (Suppl 1):15–19. doi: 10.1159/000216904. [DOI] [PubMed] [Google Scholar]
- Clagett G. P., Anderson F. A., Jr, Heit J., Levine M. N., Wheeler H. B. Prevention of venous thromboembolism. Chest. 1995 Oct;108(4 Suppl):312S–334S. doi: 10.1378/chest.108.4_supplement.312s. [DOI] [PubMed] [Google Scholar]
- Lensing A. W., Prins M. H., Davidson B. L., Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med. 1995 Mar 27;155(6):601–607. [PubMed] [Google Scholar]
- Levine M., Gent M., Hirsh J., Leclerc J., Anderson D., Weitz J., Ginsberg J., Turpie A. G., Demers C., Kovacs M. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996 Mar 14;334(11):677–681. doi: 10.1056/NEJM199603143341101. [DOI] [PubMed] [Google Scholar]
- Warkentin T. E., Levine M. N., Hirsh J., Horsewood P., Roberts R. S., Gent M., Kelton J. G. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995 May 18;332(20):1330–1335. doi: 10.1056/NEJM199505183322003. [DOI] [PubMed] [Google Scholar]